Exact Mass: 618.3125

Exact Mass Matches: 618.3125

Found 47 metabolites which its exact mass value is equals to given mass value 618.3125, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   
   

12-Ethyl-8-isobutylbacteriochlorophyllide d

12-Ethyl-8-isobutylbacteriochlorophyllide d

C36H42MgN4O4+2 (618.3056)


   

(2R,3R,4S,5R,7S,8R,13R,15R)-3,5,7,15-tetraacetoxy-8-isobutyroyloxy-9,14-dioxo-jatropha-6(17),11E-diene

(2R,3R,4S,5R,7S,8R,13R,15R)-3,5,7,15-tetraacetoxy-8-isobutyroyloxy-9,14-dioxo-jatropha-6(17),11E-diene

C33H46O11 (618.304)


   

stelleracin B

12-O-benzoylphorbol 13-(4Z,7Z)decadienoate

C37H46O8 (618.3193)


   

4-acetoxy-1beta-(2-methylbutyryloxy)-14-desacetoxy-3,14-dehydro-8,10-epoxyabrotanifolone

4-acetoxy-1beta-(2-methylbutyryloxy)-14-desacetoxy-3,14-dehydro-8,10-epoxyabrotanifolone

C33H46O11 (618.304)


   

(21alpha)-21-hydroxythyrsiferol|(alpha(2)S,2R,4S,5R)-;alpha;(2)-{(3S)-3-{(2R,4aR,6R,8aS)-6-[(2S,5R)-5-bromotetrahydro-2,6,6-trimethyl-2H-pyran-2-yl]octahydro-8a-methylpyrano[3,2-b]pyran-2-yl}-3-hydroxybutyl}tetrahydro-4-hydroxy-alpha(5),alpha(5),2-trimethylfuran-2,5-dimethanol

(21alpha)-21-hydroxythyrsiferol|(alpha(2)S,2R,4S,5R)-;alpha;(2)-{(3S)-3-{(2R,4aR,6R,8aS)-6-[(2S,5R)-5-bromotetrahydro-2,6,6-trimethyl-2H-pyran-2-yl]octahydro-8a-methylpyrano[3,2-b]pyran-2-yl}-3-hydroxybutyl}tetrahydro-4-hydroxy-alpha(5),alpha(5),2-trimethylfuran-2,5-dimethanol

C31H55BrO7 (618.3131)


   
   

Glu Ser Leu Glu Lys

Glu Ser Leu Glu Lys

C26H46N6O11 (618.3224)


   

Pro Tyr Pro Arg Ser

Pro Tyr Pro Arg Ser

C28H42N8O8 (618.3125)


   

Lys Leu Thr Asp Glu

Lys Leu Thr Asp Glu

C26H46N6O11 (618.3224)


   

[9-[(E)-3-acetyloxy-4-methylhex-4-en-2-yl]-12-hydroxy-3-(2-hydroxypropan-2-yl)-10-methoxy-6a,12b-dimethyl-8,11-dioxo-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthen-1-yl] acetate

NCGC00386086-01![9-[(E)-3-acetyloxy-4-methylhex-4-en-2-yl]-12-hydroxy-3-(2-hydroxypropan-2-yl)-10-methoxy-6a,12b-dimethyl-8,11-dioxo-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthen-1-yl] acetate

C33H46O11 (618.304)


   

PYPRS

Pro Tyr Pro Arg Ser

C28H42N8O8 (618.3125)


   

LAMER

Leu Ala Met Glu Arg

C25H46N8O8S (618.3159)


   

6-deamino-6-oxoneomycin C

6-deamino-6-oxoneomycin C

C23H48N5O14+5 (618.3198)


   

6beta-acetoxy-3beta-(beta-D-glucopyranosyloxy)-8alpha,14-dihydroxybufa-4,20,22-trienolide

6beta-acetoxy-3beta-(beta-D-glucopyranosyloxy)-8alpha,14-dihydroxybufa-4,20,22-trienolide

C33H46O11 (618.304)


   

S-linoleoyl-4-phosphopantetheine(2-)

S-linoleoyl-4-phosphopantetheine(2-)

C29H51N2O8PS-2 (618.3104)


   

(4R,7R,8S)-14-(cyclohexanecarbonylamino)-8-methoxy-4,7,10-trimethyl-11-oxo-N-[4-(trifluoromethyl)phenyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

(4R,7R,8S)-14-(cyclohexanecarbonylamino)-8-methoxy-4,7,10-trimethyl-11-oxo-N-[4-(trifluoromethyl)phenyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide

C32H41F3N4O5 (618.3029)


   

S-[2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienethioate

S-[2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]amino]propanoylamino]ethyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienethioate

C29H51N2O8PS (618.3104)


   

[9-[(E)-3-acetyloxy-4-methylhex-4-en-2-yl]-12-hydroxy-3-(2-hydroxypropan-2-yl)-10-methoxy-6a,12b-dimethyl-8,11-dioxo-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthen-1-yl] acetate

[9-[(E)-3-acetyloxy-4-methylhex-4-en-2-yl]-12-hydroxy-3-(2-hydroxypropan-2-yl)-10-methoxy-6a,12b-dimethyl-8,11-dioxo-1,2,3,4a,5,6,12,12a-octahydropyrano[3,2-a]xanthen-1-yl] acetate

C33H46O11 (618.304)


   
   

PA 16:1/11:3;O3

PA 16:1/11:3;O3

C30H51O11P (618.3169)


   
   
   
   
   

PG P-16:1/8:3;O2

PG P-16:1/8:3;O2

C30H51O11P (618.3169)


   
   
   
   
   

ST 27:5;O5;GlcA

ST 27:5;O5;GlcA

C33H46O11 (618.304)


   

ST 27:6;O6;Hex

ST 27:6;O6;Hex

C33H46O11 (618.304)


   

PAR-4 (1-6) amide (human)

PAR-4 (1-6) amide (human)

C28H42N8O8 (618.3125)


PAR-4 (1-6) amide human is an N-terminal fragment of protease-activated receptor 4 (PAR4). PAR-4 (1-6) amide human induce platelet aggregation[1].

   

({3,13,27-trihydroxy-8,14-dimethoxy-4,10,12,16,22,22-hexamethyl-20,21,23-trioxa-2-azatricyclo[16.8.1.0¹⁹,²⁵]heptacosa-1(26),2,4,6,10,18(27),19(25)-heptaen-9-yl}oxy)methanimidic acid

({3,13,27-trihydroxy-8,14-dimethoxy-4,10,12,16,22,22-hexamethyl-20,21,23-trioxa-2-azatricyclo[16.8.1.0¹⁹,²⁵]heptacosa-1(26),2,4,6,10,18(27),19(25)-heptaen-9-yl}oxy)methanimidic acid

C32H46N2O10 (618.3152)


   

2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-4-(sec-butyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-1(22),2,11,14,17,20(23)-hexaen-5-one

2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-4-(sec-butyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-1(22),2,11,14,17,20(23)-hexaen-5-one

C30H46N6O6S (618.3199)


   

(1z,3s,3as,4r,5r,6r,7s,7as)-1-ethylidene-3,5-bis({[(2r)-2-methylbutanoyl]oxy})-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydrospiro[indene-4,2'-oxiran]-6-yl (2e,4s)-4-(acetyloxy)-3-methylpent-2-enoate

(1z,3s,3as,4r,5r,6r,7s,7as)-1-ethylidene-3,5-bis({[(2r)-2-methylbutanoyl]oxy})-7-[(2s)-2-methyloxiran-2-yl]-2-oxo-hexahydrospiro[indene-4,2'-oxiran]-6-yl (2e,4s)-4-(acetyloxy)-3-methylpent-2-enoate

C33H46O11 (618.304)


   

{[13-hydroxy-23-(2-hydroxypropan-2-yl)-8,14-dimethoxy-4,10,12,16-tetramethyl-3,25-dioxo-20,22-dioxa-2-azatricyclo[16.6.1.0¹⁹,²³]pentacosa-1(24),4,6,10,18-pentaen-9-yl]oxy}methanimidic acid

{[13-hydroxy-23-(2-hydroxypropan-2-yl)-8,14-dimethoxy-4,10,12,16-tetramethyl-3,25-dioxo-20,22-dioxa-2-azatricyclo[16.6.1.0¹⁹,²³]pentacosa-1(24),4,6,10,18-pentaen-9-yl]oxy}methanimidic acid

C32H46N2O10 (618.3152)


   

(4s,10s,16s,19s)-4-[(2s)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-1(22),2,11,14,17,20(23)-hexaen-5-one

(4s,10s,16s,19s)-4-[(2s)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-1(22),2,11,14,17,20(23)-hexaen-5-one

C30H46N6O6S (618.3199)


   

{[(4e,6z,8s,9s,10e,12s,13r,14s,16r)-3,13-dihydroxy-23-(2-hydroxypropan-2-yl)-8,14-dimethoxy-4,10,12,16-tetramethyl-25-oxo-20,22-dioxa-2-azatricyclo[16.6.1.0¹⁹,²³]pentacosa-1(24),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid

{[(4e,6z,8s,9s,10e,12s,13r,14s,16r)-3,13-dihydroxy-23-(2-hydroxypropan-2-yl)-8,14-dimethoxy-4,10,12,16-tetramethyl-25-oxo-20,22-dioxa-2-azatricyclo[16.6.1.0¹⁹,²³]pentacosa-1(24),2,4,6,10,18-hexaen-9-yl]oxy}methanimidic acid

C32H46N2O10 (618.3152)


   

{[(8s,9s,12s,13r,14s,16s)-3,13,27-trihydroxy-8,14-dimethoxy-4,10,12,16,22,22-hexamethyl-20,21,23-trioxa-2-azatricyclo[16.8.1.0¹⁹,²⁵]heptacosa-1(26),2,4,6,10,18(27),19(25)-heptaen-9-yl]oxy}methanimidic acid

{[(8s,9s,12s,13r,14s,16s)-3,13,27-trihydroxy-8,14-dimethoxy-4,10,12,16,22,22-hexamethyl-20,21,23-trioxa-2-azatricyclo[16.8.1.0¹⁹,²⁵]heptacosa-1(26),2,4,6,10,18(27),19(25)-heptaen-9-yl]oxy}methanimidic acid

C32H46N2O10 (618.3152)


   

4,8,15,19,26,30-hexahydroxy-1-thia-4,9,15,20,26,31-hexaazacyclotritriaconta-8,19,30-triene-5,16,27-trione

4,8,15,19,26,30-hexahydroxy-1-thia-4,9,15,20,26,31-hexaazacyclotritriaconta-8,19,30-triene-5,16,27-trione

C26H46N6O9S (618.3047)


   

3,4,6-tris(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-13a-(2-oxopropyl)-1h,2h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

3,4,6-tris(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-13a-(2-oxopropyl)-1h,2h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

C33H46O11 (618.304)


   

(4s,10s,16s,19s)-4-[(2r)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-1(22),2,11,14,17,20(23)-hexaen-5-one

(4s,10s,16s,19s)-4-[(2r)-butan-2-yl]-2,11,14,17-tetrahydroxy-16-{[(2-methylbut-3-en-2-yl)oxy]methyl}-19-(2-methylpropyl)-21-thia-3,6,12,15,18,23-hexaazatricyclo[18.2.1.0⁶,¹⁰]tricosa-1(22),2,11,14,17,20(23)-hexaen-5-one

C30H46N6O6S (618.3199)


   

1-ethylidene-3,5-bis[(2-methylbutanoyl)oxy]-7-(2-methyloxiran-2-yl)-2-oxo-hexahydrospiro[indene-4,2'-oxiran]-6-yl 4-(acetyloxy)-3-methylpent-2-enoate

1-ethylidene-3,5-bis[(2-methylbutanoyl)oxy]-7-(2-methyloxiran-2-yl)-2-oxo-hexahydrospiro[indene-4,2'-oxiran]-6-yl 4-(acetyloxy)-3-methylpent-2-enoate

C33H46O11 (618.304)


   

(2s,3s,3ar,4r,6s,7r,12r,13ar)-3,4,6-tris(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-13a-(2-oxopropyl)-1h,2h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

(2s,3s,3ar,4r,6s,7r,12r,13ar)-3,4,6-tris(acetyloxy)-2,9,9,12-tetramethyl-5-methylidene-8,13-dioxo-13a-(2-oxopropyl)-1h,2h,3h,3ah,4h,6h,7h,12h-cyclopenta[12]annulen-7-yl 2-methylpropanoate

C33H46O11 (618.304)